drugset / Trial / NCT00129688

Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children

NCT00129688

RandomizedParallel-groupOpen-labelTreatment

Summary

Once-daily dose administration of aminoglycoside in adults is effective and economical. However, its value in febrile neutropenic children, especially in Thailand, is less well researched. In the area where Pseudomonas aeruginosa prevalence in febrile neutropenic children is low, the combination of cloxacillin and amikacin is an appropriate approach. This study would like to compare the efficacy and safety including cost between these two amikacin administrations (once-daily or twice-daily) in combination with cloxacillin as an empirical therapy in febrile neutropenic children. Hypothesis: Once-daily amikacin plus cloxacillin can be used to treat febrile neutropenic children in Khon Kaen, Thailand.

Timeline

Start
2002-04
Primary completion
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Amikacin Small molecule
Subject cloxacillin Other / unclassified

Indications